نتائج البحث 641-650 من 3062 لعملية البحث عن Cognitive Behavioral Therapy
The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with ...
... treatment of these complex injuries. ... cognitive disability, and case-fatality ... treatment, and outcomes in the course of receiving currently available ...
Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...
... therapy (PRRT) to the usual approach of treatment ... This phase II trial tests whether an exercise intervention works to improve cognitive function in breast ...
... therapies for epilepsy. A Study to Evaluate the ... cognitive function, including the risk for ... therapy. Creation of PLACENTA/Serum Repository ...
... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy, collection should be within three days prior to the end of the ...
Patients undergoing spine lumbar surgery will be asked to perform short exams/questionnaires aimed at determining cognitive ... Therapy for Epilepsy Post-Approval ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.